Patent Assignment
Reel/Frame 052102/0337
Assignment of Assignor's Interest
Recorded: 2020-03-12
Pages: 8
Assignor
TABUTEAU, HERRIOT
Executed: 2020-03-05
Assignee
AXSOME THERAPEUTICS, INC.
200 BROADWAY, 3RD FLOOR, NEW YORK, NEW YORK, 10038
Covered Properties
(14)
Pharmaceutical Compositions Comprising Meloxicam
Pharmaceutical Compositions Comprising Meloxicam
Use of Reboxetine to Treat Narcolepsy
Application:
62/943,077 →
Use of Reboxetine to Treat Narcolepsy
Application:
62/946,295 →
Combination treatment for migraine and other pain
Application:
62/955,905 →
Use of Esreboxetine to Treat Nervous System Disorders Such as Fibromyalgia
Application:
16/740,329 →
Publication:
US US20200147093A1
Use of Reboxetine to Treat Narcolepsy
Use of Esreboxetine to Treat Nervous System Disorders Such as Fibromyalgia
Application:
16/740,410 →
Publication:
US US20200147095A1
Use of Esreboxetine to Treat Nervous System Disorders Such as Fibromyalgia
Application:
16/740,411 →
Publication:
US US20200147096A1
Pharmaceutical Compositions Comprising Meloxicam
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
62/971,174 →
Pharmaceutical Compositions Comprising Meloxicam
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application:
62/978,626 →
Pharmaceutical Compositions Comprising Meloxicam
PCT:
PCT/US2020/017046 ↗
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 11, 2020
From: TABUTEAU, HERRIOT
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 052089/0385 →
Intellectual Property Security Agreement
Sep 25, 2020
From: AXSOME THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 053941/0491 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Release of Security Interest
May 22, 2025
From: HERCULES CAPITAL, INC.
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 071337/0004 →